RNA

Avidity Biosciences Stock Analysis

AI Rating

Neutral
  • Quality2/10
  • Growth↓ 0/10
  • Momentum↑ 8/10
Avidity Biosciences sales and earnings growth
RNA Growth
Low
  • Revenue Y/Y↑ 72.11%
  • EPS Y/Y↓ -71.97%
  • FCF Y/Y↓ -116.87%
Avidity Biosciences gross and profit margin trends
RNA Profitability
Neutral
  • Gross margin ↑ 100.00%
  • EPS margin↓ -3650.40%
  • ROIC↓ -52.60%
Avidity Biosciences net debt vs free cash flow
RNA Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Avidity Biosciences stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗